Genome Editing in Neurosciences

Innovations in molecular biology are allowing neuroscientists to study the brain with unprecedented resolution, from the level of single molecules to integrated gene circuits. Chief among these innovations is the CRISPR-Cas genome editing technology, which has the precision and scalability to tackle the complexity of the brain. This Colloque Médecine et Recherche has brought together experts from around the world that are applying genome editing to address important challenges in neuroscience, including basic biology in model organisms that has the power to reveal systems-level insight into how the nervous system develops and functions as well as research focused on understanding and treating human neurological disorders.

• Tipo de recurso: Book
• Fecha de publicación: 2017
• Institución: Universidad de Bogotá Jorge Tadeo Lozano
• Repositorio: Expeditio: repositorio UTadeo
• Idioma: eng
• OAI Identifier: oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14314
• Acceso en línea: https://link.springer.com/book/10.1007/978-3-319-60192-2; http://hdl.handle.net/20.500.12010/14314; https://doi.org/10.1007/978-3-319-60192-2
• Palabra clave: Neurology; Genetics; DNA; Muscular dystrophy; CRISPR; Genetic engineering; Huntington's disease; Rett syndrome; Double-strand breaks; Parkinson's disease
• License: Abierto (Texto Completo)